An elderly patient died in a clinical study of Roche Holding AG’s experimental treatment for Alzheimer’s disease, prompting ...

Roche Bros., a 20-store grocery chain, announced that its Connecticut-based supplier is acquiring a 51% stake in the company.

Roche put forward new data on two of its upcoming, non-invasive blood tests designed to help rule out a diagnosis of ...

With the formation of a new strategic partnership, Dyno Therapeutics is responsible for the development of novel AAV capsids.

Seventy-two years after the Roche family opened a meat market that grew into a Massachusetts supermarket chain, the family is ...

Early data suggest Roche’s antibody may safely and quickly remove amyloid plaque for patients with Alzheimer’s disease, though the mid-stage study has been tied to one death. | Early data suggest ...

An experimental Alzheimer’s therapy from Roche successfully cleared a protein that’s a hallmark of the disease from patients’ ...

With U.S. sales of $392 million in the third quarter, Regeneron’s high-dose version of Eylea is closing in on blockbuster sales in its first full year on the market. The bad news for the company, ...

Roche explains exactly how he harnessed the science of heat training to deliver his unlikely time at the scorching 100-mile ...

George Church-founded Dyno Therapeutics Inc. is adding to its list of pharma deals by signing a second research collaboration ...

It all started in 1960 when two French families with furniture shops, helmed by the Roches and the Chouchans, decided to join ...

Roche’s first hot ‘kūmara’Brian Roche begins his job as public service commissioner this week, and the appointment of an ...